Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Burning Rock Biotech LtdBNR · Entity 6765 | Director | June 11, 2026 | July 02, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Burning Rock Biotech Ltd
Report date June 11, 2026 · Filed July 02, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary Shares (represented by American depositary shares)SEC Table I · non-derivative | Direct | 18,404,086 |
Last balance in matching sequence
After 2026-06-26 transaction · row 7
Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
7 source rowsRow 1 · 2026-06-11 · Purchase · Acquired 24,760 · Balance 17,697,436 F1: One American depositary share represents ten Class A ordinary shares. F2: The reported price is the price of each ADS acquired. Row 2 · 2026-06-12 · Purchase · Acquired 210,000 · Balance 17,907,436 F1: One American depositary share represents ten Class A ordinary shares. F2: The reported price is the price of each ADS acquired. Row 3 · 2026-06-16 · Purchase · Acquired 111,110 · Balance 18,018,546 F1: One American depositary share represents ten Class A ordinary shares. F2: The reported price is the price of each ADS acquired. Row 4 · 2026-06-22 · Purchase · Acquired 104,650 · Balance 18,123,196 F1: One American depositary share represents ten Class A ordinary shares. F2: The reported price is the price of each ADS acquired. Row 5 · 2026-06-23 · Purchase · Acquired 5,990 · Balance 18,129,186 F1: One American depositary share represents ten Class A ordinary shares. F2: The reported price is the price of each ADS acquired. Row 6 · 2026-06-24 · Purchase · Acquired 250,000 · Balance 18,379,186 F1: One American depositary share represents ten Class A ordinary shares. F2: The reported price is the price of each ADS acquired. Row 7 · 2026-06-26 · Purchase · Acquired 24,900 · Balance 18,404,086 F1: One American depositary share represents ten Class A ordinary shares. F2: The reported price is the price of each ADS acquired. |
Filing footnotes · ownership attribution and instrument terms
F1: One American depositary share represents ten Class A ordinary shares.
F2: The reported price is the price of each ADS acquired.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 26, 2026 Filed Jul 2, 2026 12:30 UTC | Burning Rock Biotech Ltd BNR · Entity 6765 | PurchaseOrdinary Shares (represented by American depositary shares) | 24,900 | $8.00 | $199,090.44 |
DisclosureSEC source: 0001193125-26-293511 · ownership.xml · nonDerivative · entry 7 Han Yusheng · CIK 0001843554 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,404,086 F1 · security: One American depositary share represents ten Class A ordinary shares. F2 · price: The reported price is the price of each ADS acquired. Read SEC document |
| June 24, 2026 Filed Jul 2, 2026 12:30 UTC | Burning Rock Biotech Ltd BNR · Entity 6765 | PurchaseOrdinary Shares (represented by American depositary shares) | 250,000 | $8.00 | $2,000,000.00 |
DisclosureSEC source: 0001193125-26-293511 · ownership.xml · nonDerivative · entry 6 Han Yusheng · CIK 0001843554 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,379,186 F1 · security: One American depositary share represents ten Class A ordinary shares. F2 · price: The reported price is the price of each ADS acquired. Read SEC document |
| June 23, 2026 Filed Jul 2, 2026 12:30 UTC | Burning Rock Biotech Ltd BNR · Entity 6765 | PurchaseOrdinary Shares (represented by American depositary shares) | 5,990 | $7.50 | $44,920.21 |
DisclosureSEC source: 0001193125-26-293511 · ownership.xml · nonDerivative · entry 5 Han Yusheng · CIK 0001843554 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,129,186 F1 · security: One American depositary share represents ten Class A ordinary shares. F2 · price: The reported price is the price of each ADS acquired. Read SEC document |
| June 22, 2026 Filed Jul 2, 2026 12:30 UTC | Burning Rock Biotech Ltd BNR · Entity 6765 | PurchaseOrdinary Shares (represented by American depositary shares) | 104,650 | $7.45 | $779,673.90 |
DisclosureSEC source: 0001193125-26-293511 · ownership.xml · nonDerivative · entry 4 Han Yusheng · CIK 0001843554 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,123,196 F1 · security: One American depositary share represents ten Class A ordinary shares. F2 · price: The reported price is the price of each ADS acquired. Read SEC document |
| June 16, 2026 Filed Jul 2, 2026 12:30 UTC | Burning Rock Biotech Ltd BNR · Entity 6765 | PurchaseOrdinary Shares (represented by American depositary shares) | 111,110 | $9.00 | $999,956.67 |
DisclosureSEC source: 0001193125-26-293511 · ownership.xml · nonDerivative · entry 3 Han Yusheng · CIK 0001843554 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,018,546 F1 · security: One American depositary share represents ten Class A ordinary shares. F2 · price: The reported price is the price of each ADS acquired. Read SEC document |
| June 12, 2026 Filed Jul 2, 2026 12:30 UTC | Burning Rock Biotech Ltd BNR · Entity 6765 | PurchaseOrdinary Shares (represented by American depositary shares) | 210,000 | $9.25 | $1,942,143.00 |
DisclosureSEC source: 0001193125-26-293511 · ownership.xml · nonDerivative · entry 2 Han Yusheng · CIK 0001843554 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,907,436 F1 · security: One American depositary share represents ten Class A ordinary shares. F2 · price: The reported price is the price of each ADS acquired. Read SEC document |
| June 11, 2026 Filed Jul 2, 2026 12:30 UTC | Burning Rock Biotech Ltd BNR · Entity 6765 | PurchaseOrdinary Shares (represented by American depositary shares) | 24,760 | $8.74 | $216,387.54 |
DisclosureSEC source: 0001193125-26-293511 · ownership.xml · nonDerivative · entry 1 Han Yusheng · CIK 0001843554 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,697,436 F1 · security: One American depositary share represents ten Class A ordinary shares. F2 · price: The reported price is the price of each ADS acquired. Read SEC document |
| March 31, 2026 Filed Apr 2, 2026 11:17 UTC | Burning Rock Biotech Ltd BNR · Entity 6765 | PurchaseOrdinary Shares (represented by American depositary shares) | 314,870 | $17.36 | $5,466,143.20 |
DisclosureSEC source: 0001193125-26-138961 · ownership.xml · nonDerivative · entry 1 Han Yusheng · CIK 0001843554 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,672,676 F1 · security: One American depositary share represents ten Class A ordinary shares. F2 · price: The price reported is the weighted average price of American depositary shares. These American depositary shares were purchased in multiple transactions at prices ranging from $16.10 to $18.99. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.